Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIs
Hao Zhang(Qingdao University), San‐Qi Zhang(Xi'an Jiaotong University), Minhang Xin(Zhejiang University), Yuan‐Yuan Hei(Xi'an Jiaotong University), Weiming Duan(Xi'an Jiaotong University), Jin Wang(Xi'an Technological University), Huiyan Wang(Xi'an Jiaotong University), Hongyi Zhao(Xi'an Jiaotong University), Yong‐Xiao Cao(Xi'an Jiaotong University), Ying Shen(Hebei Medical University)
Cited by 49
Related Papers
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
Cross-talk between JNK/SAPK and ERK/MAPK Pathways
|Journal of Biological Chemistry|2003|185
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
|European Journal of Medicinal Chemistry|2018|168
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120